B-RAF with PLX4032

From Proteopedia

Revision as of 17:34, 5 October 2010 by Jens Hemmingsen (Talk | contribs)
Jump to: navigation, search

B-RAF with PLX4032

PLX4032 is a newly synthesized drug that is being used to treat malignant melanoma with a specific mutation. The mutation is B-RAF^(V600E). This drug is highly selective for this mutation and will not bind to wild type B-RAF.










testcaption

Drag the structure with the mouse to rotate

testcaption

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

J.D. Woodruff, Jens Hemmingsen, Michal Harel

Retrieved from "http://52.214.119.220/wiki/index.php/B-RAF_with_PLX4032"
Personal tools